Nuclear protein kinase C-δ: A possible check-point of cell cycle progression

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 2, 2006, Pages 287-291

  Marchisio, M ^a   Bertagnolo, V ^b   Lanuti, P ^a   Gaspari, A R ^a   Paludi, M ^a   Ciccocioppo, F ^a   Ercolino, E ^a   Bascelli, A ^a   Cataldi, A ^a   Miscia, Sebastiano ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Protein kinase C and cell cycle

Indexed keywords

PROTEIN KINASE C DELTA; PROTEIN SERINE KINASE; THREONINE;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELLULAR DISTRIBUTION; CHROMOSOME CONDENSATION; CHROMOSOME STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL LINE; METAPHASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 33746857254     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900206     Document Type: Article

References (29)

1. Di Pietro R., L. Centurione, N. Sabatini, D. Bosco, S. Sancilio, F. Garaci, R. Rana and A. Cataldi. 2004. Caspase-3 is dually regulated by apoptogenic factors mitochondrial release and by SAPK/JNK metabolic pathway in leukemic cells exposed to etoposide-ionizing radiation combined treatment. Int. J. Immunopathol. Pharmacol. 17:181.
2. Pannellini T., M. Iezzi, E. Di Carlo, E. Eleuterio, A. Coletti, A. Modesti, S. Rosini, M. Neri and P. Musiani. 2004. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int. J. Immunopathol. Pharmacol. 17:171.
3. Alexandrakis M.G., D.S. Kyriakou, D. Seretakis, W. Boucher, R. Letourneau, D. Kempuraj and T.C. Theoharides. 2003. Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1). Int. J. Immunopathol. Pharmacol. 16:43.
4. Toker A. 1998. Signaling through protein kinase C. Front. Biosci. 3:1134.
5. Mellor H. and P.J. Parker. 1998. The extended protein kinase C superfamily. Biochem. J. 332:281.
6. Schonwasser D.C., R.M. Marais, C.J. Marshall and P.J. Parker. 1998. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel and atypical protein kinase C isotypes. Mol. Cell. Biol. 18:790.
7. Lee S.J., C.K. Cho, S.Y. Yoo, T.H. Kim and Y.S. Lee. 1999. Influence of ionizing radiation on induction of apoptotic cell death and cellular redistribution of protein kinase C isozymes in mouse epidermal cells differing in carcinogenesis stages. Mutat. Res. 426:41.
8. Spitaler M., B. Wiesenhofer, U. Biadermann, T. Seppi, J. Zimmermann, M. Grumicke and J. Hofmann. 1999. The involvement of protein kinase C isoenzymes alpha, epsilon and zeta in the sensitivity to antitumor treatment and apoptosis induction. Anticancer Res. 19:3969.
9. La Porta C.A., L. Tessitore and R. Comolli. 1997. Changes in protein kinase C alpha, delta and in nuclear beta isoform expression in tumour and lung metastatic nodules induced by diethylnitrosamine in the rat. Carcinogenesis 18:715.
10. Marchisio M., G.M. Sabatino, A. Albanese, E. Santavenere, R. Buonaguidi and S. Miscia. 2004. Novel evidence of PLC δ2 involvement in the regulation of the differential evolution of human aneurysm. Int. J. Immunopathol. Pharmacol. 17:381.
11. Cataldi A., R. Di Pietro, L. Centurione, A. Grilli, G. Cutroneo and S. Miscia. 2000. Phosphatidylinositol-3-kinase activation and atypical protein kinase C zeta phosphorylation characterize the DMSO signalling in erythroleukemia cells. Cell. Signall. 12:667.
12. Chou M.M., W. Hou, J. Johson, L.K. Graham, M.H. Lee, C.S. Chen, A.C. Newton, B.S. Schaffausen and A. Toker. 1998. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr. Biol. 19:1069.
13. D'Santos C.S., J.H. Clarke and N. Divecha. 1998. Phospholipid signalling in the nucleus. Een DAG uit het leven van de inositide signalering in de nucleus. Biochim. Biophys. Acta 1436:201.
14. Buchner K. 1995. Protein kinase C in the transduction of signals toward and within the cell nucleus. Eur. J. Biochem. 228:211.
15. Marchisio M., P.M. Grimley, A. Di Baldassarre, E. Santavenere and S. Miscia. 2003. Novel shift of JAK/STAT signalling characterizes the protective effect of aurintricarboxylic acid (ATA) from tumor necrosis factor-α toxicity in human B lymphocytes. Int. J. Immunopathol. Pharmacol. 17:5.
16. Marchisio M., E. Santavenere, M. Paludi, A.R. Gaspari, P. Lanuti, A. Bascelli, E. Ercolino, A. Di Baldassarre and S. Miscia. 2005. Erythroid cell differentiation is characterized by nuclear matrix localization and phosphorylation of Protein Kinases C (PKC) α, δ and ζ. J. Cell. Physiol. 205:32.
17. Gschwendt M., H.J. Muller, K. Kielbassa, R. Zang, W. Kittstein, G. Rincke and F. Marks. 1994. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199:93.
18. Spitaler M. and D.A. Cantrell. 2004. Protein kinase C and beyond. Nature Immunol. 5:785.
19. Goss V.L., B.A. Hocevar, L.J. Thompson, C.A. Stratton, D.J. Burns and A.F. Fields. 1994. Identification of nuclear beta II protein kinase C as a mitotic lamin kinase. J. Biol. Chem. 269:19074.
20. Kikkawa U., H. Matsuzaki and T. Yamamoto. 2002. Protein kinase C delta (PKC delta): activation mechanisms and functions. J. Biochem. 132:831.
21. Steinberg S.F. 2004. Distinctive activation mechanisms and functions for protein kinase C delta. Biochem. J. 384:449.
22. Ginnan R. and H.A. Singer. 2005. PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 288:1193.
23. Nakashima S. 2002. Protein kinase C alpha (PKC alpha): regulation and biological function. J. Biochem. 132:669.
24. Griffiths G., B. Garrone, E. Deacon, P. Owen, J. Pongracz, G. Mead, A. Bradwell, D. Watters and J. Lord. 1996. The polyether bistratene A activates protein kinase C-delta and induces growth arrest in HL60 cells. Biochem. Biophis. Res. Commun. 222: 802.
25. Wang Q., X. Wang and B.M. Evers. 2003. Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B. J. Biol. Chem. 278: 51091.
26. Ashton A.W., G. Watanabe, C. Albanese, E.O. Harrington, J.A. Ware and R.G. Pestell. 1999. Protein kinase C-delta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1). J. Biol. Chem. 274:20805.
27. Yokozeki T., K. Homma, S. Kuroda, U. Kikkawa, S. Ohno, M. Takahashi, K. Imahori and Y. Kanaho. 1998. Phosphatidic acid-dependent phosphorylation of a 29-kDa protein by protein kinase Calpha in bovine brain cytosol. J. Neurochem. 71:410.
28. Centurione L., C. Di Giulio, E. Santavenere, M. Cacchio, N. Sabatini, C. Rapino, G. Bianchi, M. Rapino, D. Bosco, A. Antonucci and A. Cataldi. 2005. Protein kinase C zeta regulation of hypertrophic and apoptotic events occurring during rat neonatal heart development and growth. Int. J. Immunopathol. Pharmacol. 18:49.
29. Appert-Collin A., F.H. Duong, P. Passilly Degrace, A. Bennasroune, P. Poindron, J.M. Warter and J.P. Gies. 2005. Xaliproden (SR57746A) induces 5-HT1A receptor-mediated MAP kinase activation in PC12 cells. Int. J. Immunopathol. Pharmacol. 8:233.